NOTE: You either have javascript disabled or have saved the page locally. Your experience may not be optimal due to these factors. Please consider enabling javascript or revisiting this page to get an optimal MCD experience. (Due to browser security settings, directly clicking the previous link may not work, so you may need to copy and paste the following link [http://www.cms.gov/medicare-coverage-database/details/technology-assessments-details.aspx?TAId=54&fromdb=true] into your browser.)

Positron Emission Tomography for Nine Cancers (Bladder, Brain, Cervical, Kidney, Ovarian, Pancreatic, Prostate, Small Cell Lung, Testicular)

Select the ’Print Record’, ‘Add to Basket’ or ‘Email Record’ buttons to print the record, to add it to your basket or to email the record.

Issue

Positron emission tomography (PET) is a form of nuclear medicine imaging that detects and establishes metabolic abnormalities in tissue. A PET scanner produces an image of the area of interest through the detection of radiation emitted from a positron-emitting radionuclide that is introduced into the patient and that accumulates in the target tissue.

Technology Assessment

Download Technology Assessment [PDF, 2MB]

Download appendices [PDF, 3MB]

MEDCAC Meeting

8/20/2008 - FDG Positron Emission Tomography (PET) for 9 Cancers (brain, cervical, small cell lung, ovarian, pancreatic, testicular, prostate, bladder and kidney

Footer Links

Positron Emission Tomography for Nine Cancers (Bladder, Brain, Cervical, Kidney, Ovarian, Pancreatic, Prostate, Small Cell Lung, Testicular)

Footer

CMS & HHS Websites

Tools

Helpful Links